NY2267

CAS No. 886053-73-2

NY2267( Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester )

Catalog No. M24905 CAS No. 886053-73-2

NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 In Stock
10MG 357 In Stock
25MG 597 In Stock
50MG 851 In Stock
100MG 1152 In Stock
500MG 2313 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NY2267
  • Note
    Research use only, not for human use.
  • Brief Description
    NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
  • Description
    NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    c-Myc
  • Recptor
    c-Myc-Max
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    886053-73-2
  • Formula Weight
    637.78
  • Molecular Formula
    C38H43N3O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 250 mg/mL (392.00 mM; Need ultrasonic and warming)
  • SMILES
    O=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang Xu,et al. A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem. 2006 Apr 15;14(8):2660-73.
molnova catalog
related products
  • 10058-F4

    10058-F4 is a specific c-Myc inhibitor that disrupts the association between the c-Myc and Max.

  • Nicotinamide-N-oxide

    Nicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.

  • CBL0137

    CBL0137 (Curaxin CBL0137) is a histone chaperone FACT (facilitates chromatin transcription) and MYC signal inhibitor that markedly reduced tumor initiation and progression in vivo.